The effects of fluocinolone acetonide (FA), retinoic acid (RA), and tosylphenylalanine chloromethyl ketone (TPCK) on two-stage promotion after 7,12-dimethylbenzfaJ anthracene (DMBA) initiation in female Sencar mice were investigated. The two-stage promotion protocol was achieved by twice weekly applications of 2 sg of 12Otetradecanoylphorbol 13-acetate (TPA) for 2 weeks (stage I) followed by twice Carcinogenesis in the skin can be induced by the sequential application of a subthreshold dose of a carcinogen (initiation phase) followed by repetitive treatment with a noncarcinogenic tumor promoter. The initiation phase requires only a single application of either a direct-acting carcinogen or a procarcinogen (which has to be metabolized before being active) and is essentially irreversible; the promotion phase is initially reversible but later becomes irreversible. This system not only has provided an important model for studying carcinogenesis and for bioassaying carcinogenic agents, but it is also one of the best systems for investigating the effects of inhibitors of chemical carcinogenesis (1). Recent data from our laboratory suggest that the tumor promotion stage can be divided into two stages (2, 3). The first stage can be effectively brought about by limited applications of 12-0-tetradecanoylphorbol 13-acetate (TPA), or, to a lesser degree, of 4-0-methyl-TPA. Mezerein, a diterpene similar to TPA in its biochemical and morphological effects but a weak promoter, is a-potent stage II promoter when given repetitively after stage I promotion (2-4). The combined treatment after tumor initiation will give a tumor response similar to single-stage or complete promotion by TPA (3, 4).We have recently reported (3) that the only major biochemical and morphological difference between the effects of TPA and mezerein on the skin is the ability of TPA to induce a large number of dark basal keratinocytes, which suggests that these dark cells are important in stage I of promotion. The importance of these dark basal keratinocytes in tumor promotion was originally reported by Raick and coworkers (5-8). They found that TPA induced the appearance of these cells in the epidermis whereas ethylphenylpropiolate did not (5-8).The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
2251Inhibitors of tumor promotion have been useful in the identification of important events in tumor promotion. This has been especially true for anti-inflammatory steroids, retinoids, and protease inhibitors (1,(9)(10)(11)(12)(13)(14). These agents all are potent inhibitors of tumor promotion and chemical carcinogenesis in general (9-18). The purpose of this study was to determine the effects of some inhibitors of tumor promotion on the first and second stages of promotion and their effect on TPA-induced dark, basal keratinocytes. Tosylphenylalanyl chloromethyl ketone (TPCK) was found to inhibi...